A Plus Biotechnology Co

A Plus Biotechnology Co EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of A Plus Biotechnology Co (6918.TWO) as of Oct 19, 2026 is 185.53 M TWD. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was 171.46 M TWD — a change of 8.21% (higher).

EBITDA

185.53 MTWD

YoY

8.21%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of A Plus Biotechnology Co is 2024 185.53 M TWD. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of A Plus Biotechnology Co was 2023 171.46 M TWD. It decreases by 8.21% higher compared to the previous year.

The A Plus Biotechnology Co EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2019
44.43 M TWD
Jan 1, 2020
44.94 M TWD
Jan 1, 2021
50.02 M TWD
Jan 1, 2022
70.79 M TWD
Jan 1, 2023
171.46 M TWD
Jan 1, 2024
185.53 M TWD
The A Plus Biotechnology Co EBITDA history
YEAREBITDAYoY
185.53 MTWD+8.21%
171.46 MTWD+142.22%
70.79 MTWD+41.52%
50.02 MTWD+11.30%
44.94 MTWD+1.15%
44.43 MTWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

A Plus Biotechnology Co Stock analysis

What does A Plus Biotechnology Co do? A Plus Biotechnology Co Ltd, listed on the Taiwan Stock Exchange with ticker 6918.TWO, operates in the Health Care sector. The company is based in Taipei, Taiwan, and focuses on research, development, and manufacturing of orthopedic medical equipment. Its product portfolio includes trauma products for fracture fixation, orthopedic correction systems, artificial bone replacements, and spinal fixation devices. The company went public on January 6, 2023. Products are sold domestically and exported to mainland China, Asia, the United States, and Africa. A Plus Biotechnology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about A Plus Biotechnology Co stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of A Plus Biotechnology Co is 185.53 M TWD in 2024.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of A Plus Biotechnology Co changed from 171.46 M TWD to 185.53 M TWD, representing a 8.21% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) A Plus Biotechnology Co since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s A Plus Biotechnology Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — A Plus Biotechnology Co

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — A Plus Biotechnology Co